LEAD Agenda
Download Presentation
Watch Video
Download Presentation
Watch Video
Friday, October 13, 2023
Rachna Shroff, MD, MS, FASCO
Ana Velázquez Mañana, MD, MSc
Julie Vose, MD, MBA
Hala Borno, MD
Julie Gralow, MD, FACP, FASCO
Barbara McAneny, MD
Teresa Ramirez Montagut, MD, PhD
Moderated by Neha Mehta-Shah, MD
10:45 AM
BREAK
11:00 AM
12:30 PM
Sumanta Pal, MD, FASCO & Nazli Dizman, MD
Teresa Ramirez Montagut, MD, PhD
3:45 PM
Download Presentation
Watch Video
Download Presentation
Watch Video
Saturday, October 14
10:20 AM
Break
- Rising Star
- Woman Oncologist of the Year
Time (CST)
Friday, April 21
1:00 PM – 1:05 PM
Welcome and Introductions
1:05 PM – 2:30 PM
1:05 – 1:10 PM Pre-session ARS
1:10 – 1:30 PM: From Cell of Origin to Mutational Landscape
David Scott, MBChB PhD
1:30 – 1:50 PM: Molecular Monitoring of Lymphoma with ctDNA
1:50 – 2:10 PM: Immune Microenvironment of Lymphoma
Stephen Ansell, MD, PhD
2:30 PM – 2:50 PM
Break & Exhibits
2:50PM – 5:00 PM
Mini Symposium on Classification and Imaging in Lymphoma
2:50 – 3:50 PM: Keynote: Evolution in the Classification of Lymphoma: From WHO to ICC – Where do we go from here?
3:50 – 4:30 PM: PET Imaging in Lymphoma
- 3:50 – 4:10 PM: Historical Perspectives
- 4:10 – 4:30 PM: Future Directions
4:30 – 4:50 PM: How Many Scans are Too Many?
Carrie Thompson, MD, MS
4:50 – 5:10 PM: Panel discussion, Q&A, and Post-session ARS
5:10 PM
General Session Wrap Up and Summary
Time (CST)
Saturday, April 22
8:00 AM – 8:05 AM
Welcome and Introductions
8:00 AM – 8:25 AM
Practical Strategies for Diversity, Equity, and Inclusion in Clinical Lymphoma Research
Ruemu Birhiray, MD
8:25 AM – 9:50 AM
Mini Symposium on Hodgkin Lymphoma
8:25 – 8:30 AM: Pre-session ARS
8:35 – 8:55 AM: Frontline Approaches for Previously Untreated HL
Jonathan Friedberg, MD, MMSc
8:55 – 9:15 AM: Treating Relapsed/Refractory HL
Ann LaCasce, MD, MMSc
9:15 – 9:35 AM: Caring for Older/Comorbid Patients with HL
Andrew Evens, DO, MBA, MSc
9:35 – 9:50 AM: Panel discussion with speakers, Q&A, and post-session ARS
9:50 AM – 10:10 AM
Break & Virtual Exhibit
10:10 AM – 12:00 PM
20 Years of IUCLS
10:10 – 10:15 AM: Pre-session ARS
10:15 – 10:35 AM: A Look Back at 20 Years of IUCLS
10:35 – 11:15 AM: “Dual” Keynote Symposium: A Look at the Advancement of Lymphoma Therapy Over the Last 20 Years
- The Evolution of Novel Therapies in MCL
Michael Williams, MD - Incorporation of Bispecific Antibodies into Lymphoma Therapy
Nancy Bartlett, MD
11:15 – 11:55 AM: “Duel” Keynote Symposium: Experts Debate the Role of Transplant in PTCL
- Pro
- Con – Ranjana Advani, MD
11:55 AM – 12:00 PM: Panel discussion, Q&A, and Post-session ARS
12:00 PM – 1:00 PM
Lunch & Exhibits
1:00 PM – 2:25 PM
Mini Symposium on Transplant and Cellular Therapy
1:00 – 1:05 PM: Pre-session ARS
1:05 – 1:25 PM: Where do Auto and Allo SCT Have a Role in Lymphoid Malignancies?
1:25 – 1:45 PM: Sequencing of CAR T-cell Therapy
1:45 – 2:05 PM: Resistance to Cellular Therapy
Catherine Bollard, MD, MBChB
2:05 – 2:25 PM: Panel discussion with speakers, Q&A, and post-session ARS
2:25 PM – 2:45 PM
Break & Virtual Exhibits
2:45 PM – 4:10 PM
Mini Symposium on Follicular Lymphoma
2:45 – 2:50 PM: Pre-session ARS
2:50 – 3:10 PM: Historical Perspectives of FL
Leo Gordon, MD
3:10 –3:30 PM: Future Directions in the Treatment of FL
Brad Kahl, MD
3:30 – 3:50 PM: Current Gaps of Treatment
Loretta Nastoupil, MD
3:50 – 4:10 PM: Panel discussion, Q&A, and Post-session ARS
4:10 – 4:30PM
Summary and Best of IUCLS
4:30 PM
Adjourn